|
1
|
Maron BJ, Towbin JA, Thiene G,
Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE and Young
JB: American Heart Association; Council on Clinical Cardiology,
Heart Failure and Transplantation Committee; Quality of Care and
Outcomes Research and Functional Genomics and Translational Biology
Interdisciplinary Working Groups; Council on Epidemiology and
Prevention: Contemporary definitions and classification of the
cardiomyopathies: an American Heart Association Scientific
Statement from the Council on Clinical Cardiology, Heart Failure
and Transplantation Committee; Quality of Care and Outcomes
Research and Functional Genomics and Translational Biology
Interdisciplinary Working Groups; and Council on Epidemiology and
Prevention. Circulation. 113:1807–1816. 2006.
|
|
2
|
Sen-Chowdhry S and McKenna WJ: Sudden
death from genetic and acquired cardiomyopathies. Circulation.
125:1563–1576. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Towbin JA, Lowe AM, Colan SD, Sleeper LA,
Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, Canter C,
Wilkinson JD and Lipshultz SE: Incidence, causes, and outcomes of
dilated cardiomyopathy in children. JAMA. 296:1867–1876. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McNally EM, Golbus JR and Puckelwartz MJ:
Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin
Invest. 123:19–26. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Refaat MM, Lubitz SA, Makino S, Islam Z,
Frangiskakis JM, Mehdi H, Gutmann R, Zhang ML, Bloom HL, MacRae CA,
Dudley SC, Shalaby AA, Weiss R, McNamara DM, London B and Ellinor
PT: Genetic variation in the alternative splicing regulator RBM20
is associated with dilated cardiomyopathy. Heart Rhythm. 9:390–396.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Disertori M, Quintarelli S, Grasso M,
Pilotto A, Narula N, Favalli V, Canclini C, Diegoli M, Mazzola S,
Marini M, Del Greco M, Bonmassari R, Masè M, Ravelli F, Specchia C
and Arbustini E: Autosomal recessive atrial dilated cardiomyopathy
with standstill evolution associated with mutation of Natriuretic
Peptide Precursor A. Circ Cardiovasc Genet. 6:27–36. 2013.
View Article : Google Scholar
|
|
7
|
Paavola J, Schliffke S, Rossetti S, Kuo
IY, Yuan S, Sun Z, Harris PC, Torres VE and Ehrlich BE:
Polycystin-2 mutations lead to impaired calcium cycling in the
heart and predispose to dilated cardiomyopathy. J Mol Cell Cardiol.
58:199–208. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wahbi K, Béhin A, Bécane HM, Leturcq F,
Cossée M, Laforêt P, Stojkovic T, Carlier P, Toussaint M, Gaxotte
V, Cluzel P, Eymard B and Duboc D: Dilated cardiomyopathy in
patients with mutations in anoctamin 5. Int J Cardiol. 168:76–79.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oka T, Xu J and Molkentin JD:
Re-employment of developmental transcription factors in adult heart
disease. Semin Cell Dev Biol. 18:117–131. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Molkentin JD: The zinc finger-containing
transcription factors GATA-4, -5, and -6. Ubiquitously expressed
regulators of tissue-specific gene expression. J Biol Chem.
275:38949–38952. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liang Q, De Windt LJ, Witt SA, Kimball TR,
Markham BE and Molkentin JD: The transcription factors GATA4 and
GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J
Biol Chem. 276:30245–30253. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
van Berlo JH, Elrod JW, van den Hoogenhof
MM, York AJ, Aronow BJ, Duncan SA and Molkentin JD: The
transcription factor GATA-6 regulates pathological cardiac
hypertrophy. Circ Res. 107:1032–1040. 2010.PubMed/NCBI
|
|
13
|
Bisping E, Ikeda S, Kong SW, Tarnavski O,
Bodyak N, McMullen JR, Rajagopal S, Son JK, Ma Q, Springer Z, Kang
PM, Izumo S and Pu WT: Gata4 is required for maintenance of
postnatal cardiac function and protection from pressure
overload-induced heart failure. Proc Natl Acad Sci USA.
103:14471–14476. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oka T, Maillet M, Watt AJ, Schwartz RJ,
Aronow BJ, Duncan SA and Molkentin JD: Cardiac-specific deletion of
Gata4 reveals its requirement for hypertrophy, compensation, and
myocyte viability. Circ Res. 98:837–845. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Garg V, Kathiriya IS, Barnes R,
Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS,
Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC and Srivastava D:
GATA4 mutations cause human congenital heart defects and reveal an
interaction with TBX5. Nature. 424:443–447. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rajagopal SK, Ma Q, Obler D, Shen J,
Manichaikul A, Tomita-Mitchell A, Boardman K, Briggs C, Garg V,
Srivastava D, Goldmuntz E, Broman KW, Benson DW, Smoot LB and Pu
WT: Spectrum of heart disease associated with murine and human
GATA4 mutation. J Mol Cell Cardiol. 43:677–685. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang J, Fang M, Liu XY, Xin YF, Liu ZM,
Chen XZ, Wang XZ, Fang WY, Liu X and Yang YQ: A novel GATA4
mutation responsible for congenital ventricular septal defects. Int
J Mol Med. 28:557–564. 2011.PubMed/NCBI
|
|
18
|
Liu XY, Wang J, Zheng JH, Bai K, Liu ZM,
Wang XZ, Liu X, Fang WY and Yang YQ: Involvement of a novel GATA4
mutation in atrial septal defects. Int J Mol Med. 28:17–23.
2011.PubMed/NCBI
|
|
19
|
McCulley DJ and Black BL: Transcription
factor pathways and congenital heart disease. Curr Top Dev Biol.
100:253–277. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang YQ, Gharibeh L, Li RG, Xin YF, Wang
J, Liu ZM, Qiu XB, Xu YJ, Xu L, Qu XK, Liu X, Fang WY, Huang RT,
Xue S and Nemer G: GATA4 loss-of-function mutations underlie
familial tetralogy of Fallot. Hum Mutat. 34:1662–1671. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Posch MG, Boldt LH, Polotzki M, Richter S,
Rolf S, Perrot A, Dietz R, Ozcelik C and Haverkamp W: Mutations in
the cardiac transcription factor GATA4 in patients with lone atrial
fibrillation. Eur J Med Genet. 53:201–203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang JQ, Shen FF, Fang WY, Liu X and Yang
YQ: Novel GATA4 mutations in lone atrial fibrillation. Int J Mol
Med. 28:1025–1032. 2011.PubMed/NCBI
|
|
23
|
Wang J, Sun YM and Yang YQ: Mutation
spectrum of the GATA4 gene in patients with idiopathic atrial
fibrillation. Mol Biol Rep. 39:8127–8135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li RG, Li L, Qiu XB, Yuan F, Xu L, Li X,
Xu YJ, Jiang WF, Jiang JQ, Liu X, Fang WY, Zhang M, Peng LY, Qu XK
and Yang YQ: GATA4 loss-of-function mutation underlies familial
dilated cardiomyopathy. Biochem Biophys Res Commun. 439:591–596.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao L, Xu JH, Xu WJ, Yu H, Wang Q, Zheng
HZ, Jiang WF, Jiang JF and Yang YQ: A novel GATA4 loss-of-function
mutation responsible for familial dilated cardiomyopathy. Int J Mol
Med. 33:654–660. 2014.PubMed/NCBI
|
|
26
|
Kodo K, Nishizawa T, Furutani M, Arai S,
Yamamura E, Joo K, Takahashi T, Matsuoka R and Yamagishi H: GATA6
mutations cause human cardiac outflow tract defects by disrupting
semaphorin-plexin signaling. Proc Natl Acad Sci USA.
106:13933–13938. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin X, Huo Z, Liu X, Zhang Y, Li L, Zhao
H, Yan B, Liu Y, Yang Y and Chen YH: A novel GATA6 mutation in
patients with tetralogy of Fallot or atrial septal defect. J Hum
Genet. 55:662–667. 2010. View Article : Google Scholar
|
|
28
|
Maitra M, Koenig SN, Srivastava D and Garg
V: Identification of GATA6 sequence variants in patients with
congenital heart defects. Pediatr Res. 68:281–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang J, Luo XJ, Xin YF, Liu Y, Liu ZM,
Wang Q, Li RG, Fang WY, Wang XZ and Yang YQ: Novel GATA6 mutations
associated with congenital ventricular septal defect or tetralogy
of fallot. DNA Cell Biol. 31:1610–1617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zheng GF, Wei D, Zhao H, Zhou N, Yang YQ
and Liu XY: A novel GATA6 mutation associated with
congenital ventricular septal defect. Int J Mol Med. 29:1065–1071.
2012.
|
|
31
|
Huang RT, Xue S, Xu YJ and Yang YQ:
Somatic mutations in the GATA6 gene underlie sporadic
tetralogy of Fallot. Int J Mol Med. 31:51–58. 2013.
|
|
32
|
Yang YQ, Wang XH, Tan HW, Jiang WF, Fang
WY and Liu X: Prevalence and spectrum of GATA6 mutations associated
with familial atrial fibrillation. Int J Cardiol. 155:494–496.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li J, Liu WD, Yang ZL and Yang YQ: Novel
GATA6 loss-of-function mutation responsible for familial atrial
fibrillation. Int J Mol Med. 30:783–790. 2012.PubMed/NCBI
|
|
34
|
Yang YQ, Li L, Wang J, Zhang XL, Li RG, Xu
YJ, Tan HW, Wang XH, Jiang JQ, Fang WY and Liu X: GATA6
loss-of-function mutation in atrial fibrillation. Eur J Med Genet.
55:520–526. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Elliott P, O’Mahony C, Syrris P, Evans A,
Rivera Sorensen C, Sheppard MN, Carr-White G, Pantazis A and
McKenna WJ: Prevalence of desmosomal protein gene mutations in
patients with dilated cardiomyopathy. Circ Cardiovasc Genet.
3:314–322. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mestroni L, Rocco C, Gregori D, Sinagra G,
Di Lenarda A, Miocic S, Vatta M, Pinamonti B, Muntoni F, Caforio
AL, McKenna WJ, Falaschi A, Giacca M and Camerini: Familial dilated
cardiomyopathy: evidence for genetic and phenotypic heterogeneity.
Heart Muscle Disease Study Group. J Am Coll Cardiol. 34:181–190.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Suzuki E, Evans T, Lowry J, Truong L, Bell
DW, Testa JR and Walsh K: The human GATA-6 gene: structure,
chromosomal location, and regulation of expression by
tissue-specific and mitogen-responsive signals. Genomics.
38:283–290. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rémond MC, Iaffaldano G, O’Quinn MP,
Mezentseva NV, Garcia V, Harris BS, Gourdie RG, Eisenberg CA and
Eisenberg LM: GATA6 reporter gene reveals myocardial phenotypic
heterogeneity that is related to variations in gap junction
coupling. Am J Physiol Heart Circ Physiol. 301:H1952–H1964.
2011.PubMed/NCBI
|
|
39
|
Peterkin T, Gibson A and Patient R: GATA-6
maintains BMP-4 and Nkx2 expression during cardiomyocyte precursor
maturation. EMBO J. 22:4260–4273. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Holtzinger A and Evans T: Gata5 and Gata6
are functionally redundant in zebrafish for specification of
cardiomyocytes. Dev Biol. 312:613–622. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Koutsourakis M, Langeveld A, Patient R,
Beddington R and Grosveld F: The transcription factor GATA6 is
essential for early extraembryonic development. Development.
126:723–732. 1999.
|
|
42
|
Xin M, Davis CA, Molkentin JD, Lien CL,
Duncan SA, Richardson JA and Olson EN: A threshold of GATA4 and
GATA6 expression is required for cardiovascular development. Proc
Natl Acad Sci USA. 103:11189–11194. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhao R, Watt AJ, Battle MA, Li J, Bondow
BJ and Duncan SA: Loss of both GATA4 and GATA6 blocks cardiac
myocyte differentiation and results in acardia in mice. Dev Biol.
317:614–619. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Costa MW, Guo G, Wolstein O, Vale M,
Castro ML, Wang L, Otway R, Riek P, Cochrane N, Furtado M,
Semsarian C, Weintraub RG, Yeoh T, Hayward C, Keogh A, Macdonald P,
Feneley M, Graham RM, Seidman JG, Seidman CE, Rosenthal N, Fatkin D
and Harvey RP: Functional characterization of a novel mutation in
NKX2–5 associated with congenital heart disease and adult-onset
cardiomyopathy. Circ Cardiovasc Genet. 6:238–247. 2013.
|
|
45
|
Kirk EP, Sunde M, Costa MW, Rankin SA,
Wolstein O, Castro ML, Butler TL, Hyun C, Guo G, Otway R, Mackay
JP, Waddell LB, Cole AD, Hayward C, Keogh A, Macdonald P, Griffiths
L, Fatkin D, Sholler GF, Zorn AM, Feneley MP, Winlaw DS and Harvey
RP: Mutations in cardiac T-box factor gene TBX20 are associated
with diverse cardiac pathologies, including defects of septation
and valvulogenesis and cardiomyopathy. Am J Hum Genet. 81:280–291.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang YQ, Wang J, Wang XH, Wang Q, Tan HW,
Zhang M, Shen FF, Jiang JQ, Fang WY and Liu X: Mutational spectrum
of the GATA5 gene associated with familial atrial fibrillation. Int
J Cardiol. 157:305–307. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gu JY, Xu JH, Yu H and Yang YQ: Novel
GATA5 loss-of-function mutations underlie familial atrial
fibrillation. Clinics (Sao Paulo). 67:1393–1399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang XH, Huang CX, Wang Q, Li RG, Xu YJ,
Liu X, Fang WY and Yang YQ: A novel GATA5 loss-of-function mutation
underlies lone atrial fibrillation. Int J Mol Med. 31:43–50.
2013.PubMed/NCBI
|
|
49
|
Huang RT, Xue S, Xu YJ, Zhou M and Yang
YQ: A novel NKX2.5 loss-of-function mutation responsible for
familial atrial fibrillation. Int J Mol Med. 31:1119–1126.
2013.PubMed/NCBI
|
|
50
|
Xie WH, Chang C, Xu YJ, Li RG, Qu XK, Fang
WY, Liu X and Yang YQ: Prevalence and spectrum of Nkx2.5 mutations
associated with idiopathic atrial fibrillation. Clinics (Sao
Paulo). 68:777–784. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang YQ, Xu YJ, Li RG, Qu XK, Fang WY and
Liu X: Prevalence and spectrum of PITX2c mutations associated with
familial atrial fibrillation. Int J Cardiol. 168:2873–2876. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhou YM, Zheng PX, Yang YQ, Ge ZM and Kang
WQ: A novel PITX2c loss-of-function mutation underlies lone atrial
fibrillation. Int J Mol Med. 32:827–834. 2013.PubMed/NCBI
|
|
53
|
Wang J, Zhang DF, Sun YM and Yang YQ: A
novel PITX2c loss-of-function mutation associated with familial
atrial fibrillation. Eur J Med Genet. 57:25–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
